SCN1A and epilepsy: SCN1A LoF variants include Dravet syndrome, a severe drug-resistant developmental and epileptic encephalopathy in which sodium channel blockers are contraindicated, and genetic epilepsy with febrile seizures plus (GEFS+), a milder drug-responsive epilepsy form [4].